CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Bristol-Myers Squibb Co - BMY CFD

56.16
3.64%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024151 %
Charges from full value of position ($-4.59)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024151%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001929 %
Charges from full value of position ($0.37)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 58.28
Open 57.44
1-Year Change 13.92%
Day's Range 55.78 - 57.44
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 15, 2024 56.16 -1.81 -3.12% 57.97 58.21 55.77
Nov 14, 2024 58.28 0.13 0.22% 58.15 59.60 58.15
Nov 13, 2024 58.37 -0.69 -1.17% 59.06 59.41 57.78
Nov 12, 2024 58.95 -1.05 -1.75% 60.00 60.50 58.74
Nov 11, 2024 59.52 -1.10 -1.81% 60.62 60.98 59.46
Nov 8, 2024 54.09 -0.47 -0.86% 54.56 54.63 53.92
Nov 7, 2024 54.67 -0.18 -0.33% 54.85 55.46 54.42
Nov 6, 2024 55.21 -0.90 -1.60% 56.11 56.72 55.08
Nov 5, 2024 55.88 0.93 1.69% 54.95 56.22 54.61
Nov 4, 2024 55.39 1.19 2.20% 54.20 55.67 54.20
Nov 1, 2024 54.26 -1.53 -2.74% 55.79 55.80 54.15
Oct 31, 2024 55.69 2.13 3.98% 53.56 56.10 53.43
Oct 30, 2024 52.40 0.16 0.31% 52.24 53.09 52.24
Oct 29, 2024 52.45 0.52 1.00% 51.93 52.68 51.93
Oct 28, 2024 52.58 1.31 2.56% 51.27 52.70 51.27
Oct 25, 2024 51.86 -0.60 -1.14% 52.46 52.81 51.77
Oct 24, 2024 52.86 0.10 0.19% 52.76 53.34 52.36
Oct 23, 2024 52.99 0.38 0.72% 52.61 53.05 52.48
Oct 22, 2024 52.71 0.96 1.86% 51.75 53.00 51.75
Oct 21, 2024 52.07 -1.14 -2.14% 53.21 53.21 52.05

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Bristol-Myers Squibb Company profile

What is Bristol-Myers Squibb Co.?

The Bristol-Myers Squibb Company is an international biopharmaceutical company specialising in discovering, developing and delivering innovative biopharmaceutical products and medicines to patients who suffer from serious diseases. Bristol-Myers Squibb provides medicines to help people fight cancer, hepatitis B and C, cardiovascular disease, HIV and AIDS. The company supplies its products to retail and wholesale pharmacies, governmental entities, and hospitals throughout the world.
 

What’s the history behind the company?

1858 – The Squibb corporation is founded by Edward Robinson Squibb in New York.
 
1887 – The Clinton Pharmaceutical company i purchased by William McLaren Bristol and John Ripley Myers. Two years later they rename it as “Bristol, Myers and Company”, and later, following Myers death in 1899 as the “Bristol-Myers Corporation”.
 
1903 – Sal Hepatica, a laxative salt is developed and released marking the first product for the company.
 
1943 – Acquisition of Cheplin Biological Laboratories, Bristol laboratories in 1945 creating antibiotics, is met with competition from Squibbs.
 
1989 – Bristol-Myers merges with Squibb to form Bristol-Myers Squibb, creating one of the world’s largest pharmaceutical companies.
 
1998 – Development of Excedrin Migraine, one of the first migraine medications available without a prescription in the US.
 
2004 – Bristol-Myers Squibb pays $150 million in a settlement for accounting fraud, the company does not admit or deny guilt. In 2006, the company is hit again by charges and pays $2.1 million to the Federal Trade Commission.
 
2008 – The company undertakes a number of partnerships, including therapy for cardiovascular diseases with KAI pharmaceuticals, cancer therapies with Kosan, and two novel therapies for cancer with Exelixis. These collaborations continue into 2009 with more added.
 
2010 – Lamberto Andreotti took over as CEO of Bristol-Myers Squibb. By 2012, the company’s net sales reach $17.6 billion.
 
2015 – Dr. Giovanni Caforio becomes the head of the company.
 

About the company

Bristol-Myers Squibb operates worldwide with locations such as Asia, including China and Japan, Southeast Asia in Bangalore India, across Europe in Belgium, England, France, Ireland and Italy, and North America. This includes a number of research and development facilities, vital to the creation of new pharmaceutical products.
 
Across its facilities, the company employs approximately 23,700 people. To date, Dr. Giovanni Caforio is the Chairman and CEO of the company with Charles Bancroft as CFO.
 
The company has numerous awards and achievements, including 2018 Best-of-the-Best Corporations for Inclusion by National Business Inclusion Consortium, Fortune’s World’s Most Admired Companies, Dow Jones' 2017 North American Index of Leading Sustainable Companies, and Forbes America’s Best Employers for 2016.
 

Key Statistics

  • Revenue in 2017 – $20.78 billion
  • Net income in 2017 – $975 million
  • Total assets in 2017 – 33.55 billion
  • Total equity in 2017 – 11.85 billion

Major acquisitions

  • Adnexus Therapeutics – 2007
  • Kosan Biosciences – 2008
  • Medarex – 2009
  • ZymoGenetics – 2010
  • Amira Pharmaceuticals – 2011
  • Inhibitex Inc. – 2012
  • Amylin Pharmaceuticals and AstraZeneca – 2018
  • iPierian – 2014
  • Flexus Biosciences – 2015
  • Cardioxyl – 2015
  • Padlock Therapeutics – 2016
  • Cormorant Pharmaceuticals – 2016
  • IFM Therapeutics – 2017

Where is Bristol-Myers Squibb Co. traded?

Bristol-Myers Squibb is traded on the New York Stock Exchange (NYSE) under the ticker BMY. It is also a component of the S&P 100 and S&P 500. Trade the latest Bristol-Myers Squibb share price with Capital.com, explore the most up-to-date BMY charts, and delve into this pharmaceutical company.
Industry: Pharmaceuticals (NEC)

Route 206 And Province Line Road
PRINCETON
NEW JERSEY 08543
US

News

SHIB cryptocurrency logo, showing a cartoon Shiba Inu dog on a coin, over a golden orange background with circuit board graphics detail

Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target

Can Shiba Inu reinvent itself to become a worthy long-term investment?

08:36, 15 November 2024

Trump trades charge as Bitcoin hits $US80,000

Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.

10:48, 13 November 2024

Australian jobs data expected to point to solid labour market conditions

Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.

10:16, 13 November 2024

FOMC cuts interest rates as expected and sticks to its line on future policy

The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.

13:33, 8 November 2024

FOMC and BOE preview: further rate cuts expected

Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.

14:14, 5 November 2024

RBA meeting preview: No change to policy expected as inflation fight continues

The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.

13:35, 4 November 2024

US elections: Trump leads the polls, but tariff talk spooks investors

As the US elections get closer we look at how Trump’s tariff plans could affect markets.

15:02, 22 October 2024

People also watch

Gold

2,563.47 Price
-0.050% 1D Chg, %
Long position overnight fee -0.0173%
Short position overnight fee 0.0091%
Overnight fee time 22:00 (UTC)
Spread 0.60

BTC/USD

90,880.75 Price
-0.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

20,408.80 Price
-2.240% 1D Chg, %
Long position overnight fee -0.0242%
Short position overnight fee 0.0019%
Overnight fee time 22:00 (UTC)
Spread 7.0

ETH/USD

3,116.67 Price
-1.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading